Results 121 to 130 of about 11,042 (167)
Some of the next articles are maybe not open access.
Journal of Clinical Oncology, 1990
To the Editor: Levamisole use will no doubt increase following the recent report by Laurie et al and the National Cancer Institute (NCI) Clinical Alert both related to the use of levamisole/fluorouracil (5-FU) as adjuvant treatment for colon cancer. Toxicity of levamisole is generally described as mild with nausea, diarrhea, and leukopenia being the ...
L DeLorenzo, J A Stewart
openaire +1 more source
To the Editor: Levamisole use will no doubt increase following the recent report by Laurie et al and the National Cancer Institute (NCI) Clinical Alert both related to the use of levamisole/fluorouracil (5-FU) as adjuvant treatment for colon cancer. Toxicity of levamisole is generally described as mild with nausea, diarrhea, and leukopenia being the ...
L DeLorenzo, J A Stewart
openaire +1 more source
1976
In the early 1960s our laboratory was engaged in a research program designed to find a superior anthelmintic drug. We wanted it to be chemically unrelated to known drugs, potent, safe, economical, injectable, active against larval stages and active against as wide a variety of worms as possible.
openaire +2 more sources
In the early 1960s our laboratory was engaged in a research program designed to find a superior anthelmintic drug. We wanted it to be chemically unrelated to known drugs, potent, safe, economical, injectable, active against larval stages and active against as wide a variety of worms as possible.
openaire +2 more sources